The FDA announced today that it has temporarily suspended all routine domestic inspections of regulated facilities during the coronavirus outbreak.
The move is designed to protect agency employees as well as those who conduct inspections for the agency under contract at the state level and from a desire by regulated facilities to restrict visitors, according to FDA commissioner Dr. Stephen Hahn.
“Protecting the health and safety of our staff and their families is of paramount concern to the U.S. Food and Drug Administration,” Hahn said in a statement. “As a nation we must do everything we can to help slow the spread of the virus and help flatten the curve of the COVID-19 pandemic. Now more than ever, the American people are depending on us. We must ensure our workforce remains healthy to carry out the FDA’s critical public health mission to keep Americans safe.”
Get the full story on our sister site Medical Design & Outsourcing.